Skip to main content
OpenTrials

Clinical trial condition

Sezary Syndrome

Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.

262 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Sezary Syndrome trial results

Completed

Real World Observational Study of Poteligeo in Adult Patients With MF and SS (PROSPER)

NCT05455931

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • The Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Colombia University Medical Center New York, United States
  • Inova Dwight and Martha Schar Cancer Institute Fairfax, Virginia, United States
View all 19 locations
View Trial Details
Completed

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

NCT02232516

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +32 more
Locations
  • City of Hope Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
  • Weill Cornell Medicine New York, United States
View Trial Details
Completed

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

NCT06113081

Conditions
Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome, +17 more
Locations
  • Clinica di Ematologia - AOU Ospedali Riuniti delle Marche Ancona, Italy
  • S.C. Ematologia e Trapianto emopoietico - A.O. S.Giuseppe Moscati Avellino, Italy
  • Clinica Dermatologia - A.O.U. Policlinico Consorziale Bari, Italy
  • U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy
View all 21 locations
View Trial Details
Completed

IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

NCT03902184

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States
  • Irvine Medical Center Orange, California, United States
  • Stanford University Stanford, California, United States
View all 53 locations
View Trial Details

Related conditions